Metraipolis › archive › dc_01cb40c8bc9b

Intravaginal progesterone as a fertility-sparing treatment for symptomatic adenomyosis: preliminary results from a monocentric study — Europe PMC PMID:42050103

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42050103
DOI
10.1007/s00404-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-11-03T03:07:21.531Z
SHA-256 of the archived text
949e326a82987cc1e40a042cd709ee0ca077c440149890014112915d7ee4cf83
Stable URL of this page
https://metraipolis.com/documento/dc_01cb40c8bc9b

How to cite

Intravaginal progesterone as a fertility-sparing treatment for symptomatic adenomyosis: preliminary results from a monocentric study — Europe PMC PMID:42050103 — Europe PMC (en), https://europepmc.org/article/MED/42050103 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_01cb40c8bc9b (Metraipolis archive dc_01cb40c8bc9b, sha256 949e326a82987cc1e40a042cd709ee0ca077c440149890014112915d7ee4cf83)
BibTeX
@misc{dc01cb40c8bc9b,
  title = {Intravaginal progesterone as a fertility-sparing treatment for symptomatic adenomyosis: preliminary results from a monocentric study — Europe PMC PMID:42050103},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42050103},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_01cb40c8bc9b; sha256 949e326a82987cc1e40a042cd709ee0ca077c440149890014112915d7ee4cf83},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42050103. Agents can read the archived copy with the MCP tool read_document.